Μετάβαση στο περιεχόμενο
Global sound
Clinical Pharmacology Podcast with Nathan Teuscher

Clinical Pharmacology Podcast with Nathan Teuscher

από Nathan Teuscher

Τελευταίο επεισόδιο
Inter-occasion variability and shrinkage in PK modeling (Ep. 61)

Σχετικά με αυτό το podcast

I discuss clinical pharmacology and pharmacometrics topics from the perspective of drug development scientists. I share my expertise and knowledge about designing and conducting clinical pharmacology studies and discuss how to analyze the data using the most effective approaches. I draw from my experience of over 20 years working in drug development organizations and consultancies.

Επεισόδια

Τα νεότερα 20 από 61 επεισόδια

  • Inter-occasion variability and shrinkage in PK modeling (Ep. 61) · 23 λεπ. · Επεισόδιο 61Today’s episode is about inter-occasion variability and η-shrinkage. Episodes 11, 36, 44, and 45 covered diagnostics, covariate search, estimation methods, and base-model…
  • Exposure-Response modeling · 30 λεπ. · Επεισόδιο 60Today’s episode is about exposure response modeling. What is ER analysis? When is it used? How do you do it? And what tools can be used for ER modeling? Links discussed in the…
  • Renal and Hepatic Impairment (Ep. 59) · 29 λεπ. · Επεισόδιο 59Today’s episode is a discussion of renal and hepatic impairment. I review the biology of the kidney and liver and how we analyze pharmacokinetic data to assess their impact on…
  • Beyond Small Molecules—Allometric Scaling for Biologics and Engineered mAbs (Ep. 58) · 20 λεπ. · Επεισόδιο 58Today’s episode is about allometric scaling with therapeutic antibodies. I discuss differences from small molecules, how to handle antibodies with engineered Fc regions (e.g. YTE…
  • Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57) · 24 λεπ. · Επεισόδιο 57In this episode I discuss bioequivalence testing and how it was developed to support generic drug approvals, but is now a mainstream tool for all of drug development. I discuss…
  • Examining Volume of Distribution (Ep. 56) · 19 λεπ. · Επεισόδιο 56In this episode we’re going to define Volume of Distribution, look at the different types of Volume of Distribution parameters, talk about how we actually calculate it, examine…
  • Talking about data science with Mike Stackhouse (Ep. 55) · 45 λεπ. · Επεισόδιο 55This episode is an interview with Michael Stackhouse, the Chief Innovation Officer at Atorus Research. We discussed a variety of topics such as modern data science tools, why…
  • Using Accelerator Mass Spectrometry in Clinical Pharmacology · 38 λεπ. · Επεισόδιο 54This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical…
  • Using AI tools for regulatory intelligence (Ep. 53) · 21 λεπ. · Επεισόδιο 53This episode is an interview with Aruna Dhontabhaktuni, Founder and CEO of RegKey, a regulatory intelligence platform that uses AI. The discussion touches on how companies can…
  • When to use model-informed drug development (Ep. 52) · 28 λεπ. · Επεισόδιο 52This episode is a collection of my thoughts on model-informed drug development and where different modeling modalities fit into the development schedule. These are just my…
  • QSP Modeling with Ahmed Elmokadem (Ep. 51) · 45 λεπ. · Επεισόδιο 51In this episode I chat with Ahmed Elmokadem about QSP modeling. Ahmed, from Metrum Research Group, is an expert consultant in QSP modeling and how it can be used to provide a…
  • CDISC datasets and ACoP 2025 (Ep. 50) · 19 λεπ. · Επεισόδιο 50In this episode I discuss dataset-JSON, a new proposed data standard for CDISC files and explain some of the CDISC files I use in my clinical pharmacology work. I end with some…
  • Statistics in Pharmacokinetics (Ep. 49) · 25 λεπ. · Επεισόδιο 49In this episode I discuss review statistics that are commonly used in pharmacokinetics and pharmacometrics work. I reviewed the basic theory of the normal distribution and then…
  • Clinical Trial Simulations (Ep. 48) · 22 λεπ. · Επεισόδιο 48In this episode I discuss clinical trial simulations. I review concepts of trial simulation including different variability terms and when to use them. I also share my thoughts…
  • Using R Shiny for Clinical Pharmacology (Ep. 47) · 20 λεπ. · Επεισόδιο 47In this episode I discuss R Shiny and how it can be used for building clinical pharmacology tools. I provide an overview of the technology, suggest a few example use cases, and…
  • What is useful about noncompartmental analysis? (Ep. 46) · 27 λεπ. · Επεισόδιο 46In this episode I discuss noncompartmental analysis. I categorize PK parameters calculated by NCA methods as either Important, Useful, or Questionable. I also share my thoughts…
  • How to select a base PK model (Ep. 45) · 28 λεπ. · Επεισόδιο 45In this episode I review the process I follow for fitting a base pharmacokinetic (PK) model. I talk from the perspective of an individual PK model, but include some differences…
  • Different estimation methods used in modeling (Ep. 44) · 26 λεπ. · Επεισόδιο 44In this episode I discuss different algorithms used for pharmacometrics modeling. I describe difference between maximum likelihood and expectation maximization methods. I review…
  • What is consulting life like? (Ep. 43) · 30 λεπ.In this episode I discuss my experience as an independent consultant in the clinical pharmacology and pharmacometrics space. I talk about how I got from high school to become a…
  • Population PK modeling with nlmixr (Ep. 42) · 26 λεπ. · Επεισόδιο 42In this episode I discuss using nlmixr for population PK modeling in R. I give an overview of the software package, describe the installation process, and walk through a simple…

Ζωντανά, τελευταία ώρα: 13.747 τραγούδια σε 6.904 σταθμούς σε 142 χώρες

Ανακαλύψτε τον κόσμο μέσα από το ραδιόφωνο

Περισσότεροι τρόποι ανακάλυψης (9)

Ακούσατε κάτι ωραίο; Αποθηκεύστε το ή ανοίξτε το απευθείας στο Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
M'era Luna FMΣυνέχεια ακρόασης